Cargando…

Risk of SARS-CoV-2 reinfection after natural infection

Detalles Bibliográficos
Autores principales:	Boyton, Rosemary J, Altmann, Daniel M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969128/ https://www.ncbi.nlm.nih.gov/pubmed/33743219 http://dx.doi.org/10.1016/S0140-6736(21)00662-0

Ejemplares similares

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
por: Altmann, Daniel M, et al.
Publicado: (2021)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

SARS-CoV-2 reinfection in a closed setting: lessons for the community
por: Velasco, María, et al.
Publicado: (2021)

The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
por: Boyton, Rosemary J., et al.
Publicado: (2021)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
por: Altmann, Daniel M, et al.
Publicado: (2022)

The S-Trimer (SCB-2019) COVID-19 vaccine and reinfection with SARS-CoV-2
por: Li, Jing-Xin, et al.
Publicado: (2022)

SARS-CoV-2 in Malaysia: A surge of reinfection during the predominantly Omicron period
por: Yang, Su Lan, et al.
Publicado: (2022)

Diabetes after SARS-CoV-2 infection
por: Al-Aly, Ziyad
Publicado: (2023)

Effectiveness of SARS-CoV-2 vaccines in the post-natural infection world
por: Garg, Pramod Kumar, et al.
Publicado: (2022)

What policy makers need to know about COVID-19 protective immunity
por: Altmann, Daniel M, et al.
Publicado: (2020)

SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition
por: Altmann, Daniel M., et al.
Publicado: (2021)

The mechanisms of smell loss after SARS-CoV-2 infection
por: Doty, Richard L
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Protective immunity after recovery from SARS-CoV-2 infection
por: Kojima, Noah, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

SARS-CoV-2 infection and cardiac arrhythmias
por: Dewland, Thomas A., et al.
Publicado: (2022)

SARS-CoV-2 reinfection()
por: Romera, I., et al.
Publicado: (2021)

The benefit of vaccination after previous SARS-CoV-2 infection in the omicron era
por: Boaventura, Viviane S, et al.
Publicado: (2023)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

Correlates of protection from SARS-CoV-2 infection
por: Krammer, Florian
Publicado: (2021)

Escalating burden of SARS-CoV-2 infection in Ethiopia
por: Adane, Kelemework, et al.
Publicado: (2021)

Stroke after SARS-CoV-2 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Risks of lung transplantation in the SARS-CoV-2 era
por: Meyer, Keith C
Publicado: (2021)

Duration of immune protection of SARS-CoV-2 natural infection against reinfection
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Response to “the role of the exposome in promoting resilience or susceptibility after SARS-CoV-2 infection”
por: Rappaport, Stephen M.
Publicado: (2020)

First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infection
por: Perrot, Lea, et al.
Publicado: (2021)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

SARS-CoV-2 immunity and HIV infection: total recall?
por: Dauby, Nicolas, et al.
Publicado: (2021)

How to interpret the total number of SARS-CoV-2 infections
por: Shioda, Kayoko, et al.
Publicado: (2022)

Neuroinflammation triggered by SARS-CoV-2 infection: syndromes and therapies
por: Dale, Russell C, et al.
Publicado: (2021)

Early treatment to prevent progression of SARS-CoV-2 infection
por: Cohen, Myron S
Publicado: (2022)

Association of SARS-CoV-2 infection and persistence with long COVID
por: Yang, Chengliang, et al.
Publicado: (2023)

Stroke seven hours after SARS-CoV-2 vaccination
por: Fiorini, Ana Claudia, et al.
Publicado: (2023)

Balancing risk and benefit of SARS-CoV-2 vaccines in children
por: Levin, Michael, et al.
Publicado: (2022)

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9bhia33bvk9qib957i0bmvel7t